Human LHX2 has been reported to be overexpressed in chronicmyelogenous leukemia (CML) [21], but downregulated in small B-cell lymphoma [22] and lungcancer [23]. Here, LHX2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.